IMPERAGEN LIMITED
Research and experimental development on biotechnology
IMPERAGEN LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Unit 11, Williams House Lloyd Street North Manchester Science Park Manchester M15 6SE England
Full company profile for IMPERAGEN LIMITED (13761050), an active life sciences and medical technology company based in Manchester, England. Incorporated 23 Nov 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Cash in Bank
£598.56k
Net Assets
£1.52M
Total Liabilities
£89.01k
Turnover
N/A
Employees
12
Debt Ratio
6%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (2)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Aug 2022 | Seed |
| Investor 2 | Aug 2022 | Seed |
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Timothy John Eyes | Director | British | England | 23 Nov 2021 | Active |
See all 12 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
No PSC information available
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 20 Apr 2026 | Capital | Allotment of shares (GBP 21.6459) on 13 Apr 2026 | |
| 20 Apr 2026 | Capital | Allotment of shares (GBP 21.6786) on 17 Apr 2026 | |
| 17 Apr 2026 | Confirmation Statement | Replacement Filing Of Confirmation Statement With Made Up Date | |
| 27 Jan 2026 | Officers | Appointment of Mr Guy Levy-Yurista as director on 5 Jan 2026 | |
| 19 Dec 2025 | Confirmation Statement | Confirmation statement made on 6 Dec 2025 with updates |
Allotment of shares (GBP 21.6459) on 13 Apr 2026
Allotment of shares (GBP 21.6786) on 17 Apr 2026
Replacement Filing Of Confirmation Statement With Made Up Date
Appointment of Mr Guy Levy-Yurista as director on 5 Jan 2026
Confirmation statement made on 6 Dec 2025 with updates
Recent Activity
Latest Activity
Allotment of shares (GBP 21.6459) on 13 Apr 2026
2 weeks ago on 20 Apr 2026
Allotment of shares (GBP 21.6786) on 17 Apr 2026
2 weeks ago on 20 Apr 2026
Replacement Filing Of Confirmation Statement With Made Up Date
2 weeks ago on 17 Apr 2026
Appointment of Mr Guy Levy-Yurista as director on 5 Jan 2026
3 months ago on 27 Jan 2026
Confirmation statement made on 6 Dec 2025 with updates
4 months ago on 19 Dec 2025